Δημοσιεύσεις %1

Τμήμα Ιατρικής

Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης

Ο κατάλογος των δημοσιεύσεων είναι ενδεικτικός και μπορεί να μην περιλαμβάνει το σύνολο των δημοσιεύσεων.

+ Προσθέστε μια νέα δημοσίευση

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 13:30

Read more about Towards tumor immunodiagnostics.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 13:31

Read more about Overview of advances in cancer immunotherapy.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 13:32

Read more about MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 13:33

Read more about Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 13:34

Read more about Expression pattern of the Hedgehog signaling pathway in pituitary adenomas.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 13:55

Read more about Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:05

Read more about Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:06

Read more about A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:06

Read more about Sample parameters affecting the clinical relevance of RNA biomarkers in translational breast cancer research.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:07

Read more about DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:13

Read more about Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:14

Read more about Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:14

Read more about Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:35

Read more about Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:44

Read more about Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:46

Read more about A splice variant of HER2 corresponding to Herstatin is expressed in the noncancerous breast and in breast carcinomas.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:47

Read more about Revisiting OCT4 expression in peripheral blood mononuclear cells.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:48

Read more about The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:48

Read more about Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:50

Read more about In situ detection of hTERT variants in anaplastic large cell lymphoma.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:51

Read more about Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:51

Read more about Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:52

Read more about Spinal epidural extraskeletal Ewing sarcoma in an adolescent boy: a case report.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:53

Read more about Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia.

Contact Info

Submitted by Βασιλική Κωτού… on Tue, 12/01/2020 - 14:55

Read more about Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas.

Towards tumor immunodiagnostics.

Overview of advances in cancer immunotherapy.

MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.

Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.

Expression pattern of the Hedgehog signaling pathway in pituitary adenomas.

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy.

Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.

A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas.

Sample parameters affecting the clinical relevance of RNA biomarkers in translational breast cancer research.

DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome.

Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab.

Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel.

Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.

Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib.

A splice variant of HER2 corresponding to Herstatin is expressed in the noncancerous breast and in breast carcinomas.

Revisiting OCT4 expression in peripheral blood mononuclear cells.

The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.

Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.

In situ detection of hTERT variants in anaplastic large cell lymphoma.

Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.

Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.

Spinal epidural extraskeletal Ewing sarcoma in an adolescent boy: a case report.

Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia.

Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas.

Σύνδεσμοι

Το πανεπιστήμιο

Προσωπικό & Φοιτητές

Επικοινωνία

Primary tabs

Συνδεθείτε